A Narrative Review of the Prognostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) in Cardiovascular Disease

More on Cardiovascular disease

• Risk factors for atherosclerosis diverge across vascular beds

  American Journal of Preventive Cardiology · 4 Oct 2026

• Social context predicts heart risks despite normal biomarkers

  medRxiv · 4 Oct 2026

• Intereye retinal asymmetry is linked to cardiovascular risk

  Journal of the American Heart Association · 4 Oct 2026

• Blood proteins improve early cardiometabolic risk prediction

  Diabetes, Obesity & Metabolism · 4 Oct 2026